Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan
22 août 2024 09h00 HE
|
Inhibitor Therapeutics, Inc.
TAMPA, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. ("Inhibitor") (OTCQB: INTI) today provided an update on development efforts for its itraconazole formulation for the...
Honoring the Legacy of Dr. Alastair Carruthers
21 août 2024 18h11 HE
|
American Society for Dermatologic Surgery
Schaumburg, IL, Aug. 21, 2024 (GLOBE NEWSWIRE) -- It is with deep sorrow that the American Society for Dermatologic Surgery (ASDS) announces the passing of Alastair Carruthers, FRCPC, a pioneering...
Derm-Biome Pharmaceuticals to develop skincare treatment that promotes skin health and longevity
13 août 2024 10h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company focused on skin health and healthy aging, is excited to...
ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria
13 août 2024 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a leader in innovative wound care solutions, is excited to announce that a shipment of 500,000 units of its flagship...
[Latest] Global Aesthetics Injectables Market Size/Share Worth USD 35,976.2 Million by 2033 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
13 août 2024 00h30 HE
|
Custom Market Insights
Austin, TX, USA, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Aesthetics Injectables Market Size, Trends and Insights By Product Type...
Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
12 août 2024 16h01 HE
|
Journey Medical Corporation
New Drug Application for DFD-29 to treat rosacea under FDA review; PDUFA goal date of November 4, 2024 Total revenues for the second quarter ended June 30, 2024 were $14.9 million, a 14% increase...
Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome
06 août 2024 05h00 HE
|
Quoin Pharmaceuticals, Inc.
Peeling Skin Syndrome is a rare autosomal disease with no approved treatment or cure Initial clinical site and pediatric patient identified in New Zealand Company actively evaluating opening...
ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
01 août 2024 08h00 HE
|
ViaDerma, Inc.
ViaDerma announces strategic new agreements to move forward its global expansion.
Mindera Health Secures $14 Million to Advance Commercialization of First and Only Psoriasis Precision Medicine Test
31 juil. 2024 08h00 HE
|
Mindera Health
San Diego, CA, July 31, 2024 (GLOBE NEWSWIRE) -- Mindera Health Inc. announces the closing of a $14M convertible note financing, led by Mountain Group Partners and other existing investors in...
Raytech Holding Reports Financial Results for Fiscal Year Ended March 31, 2024
30 juil. 2024 06h00 HE
|
Raytech Holding Limited
HONG KONG, July 30, 2024 (GLOBE NEWSWIRE) -- Raytech Holding Limited (the “Company” or “RAY”), a Hong Kong-headquartered company specializing in design, sourcing and wholesale of personal care...